Info

🌱 來自: ESMO Checklist

ESMO Checklist_Early and Locally Advanced Non-Small Cell Lung Cancer

MEDICAL HISTORY AND RISK FACTORS

Past personal medical history and vascular risk factors: Past surgical history: Concurrent medication: Allergies: Smoking history: pack/y from age to age__ Alcohol consumption:

---

PHYSICAL EXAM

(PRESENT MEDICAL CONDITIONS) Normal weight: Height: BMI Main symptoms: Weight loss: ECOG Performance Status: ENT Examination: alert<> and oriented<>, appeared in no distress<> No< Anemia > conjunctival pallor,<> no<> scleral icterus HEENT: no<> oral thrush,<> no neck LAP Chest: bilateral<> clear<> breath sounds Heart: regular rhythm,<> normal rate,<>no murmur Abd: non<>distended, normo<>active BoS, nontender Ext: warm, <bilateral 2+>no<> pitting edema

Assessment

Lung adenocarcinoma

DIAGNOSIS AND CLINICAL STAGING

• < date > PET/CT scan:
• < date > Bronchoscopy:
• < date > EBUS/EUS:
• < date > TNM stage and grade:

HISTOLOGICAL ANALYSIS

• Core biopsy of primary tumour:
• Non-squamous:
  • Tested for EGFR mut. PD-L1, method used
• Squamous:
  • Tested for PD-L1, method used
• Tissue material available/stored for future molecular analyses YES NO
• CBC/DC, Liver Enzymes, LDH, Calcium, Albumin, Renal, Function
• IF the patient is scheduled for radical treatment, the following tests have been considered
  • (Stage III) Brain MRI, preferably to contrast-enhanced CT-scan
  • Lung function tests
  • Cardio-vascular check-up
• Timeline for further work-up has been checked and it is tight enough

MDT discussion and decision

• Treatment options have been discussed with the patient and strategy accepte
  • Surgery Performed Planned
  • SBRT Radiotherapy Radiofrequency ablation (or similar ablative approach)
  • Neoadjuvant chemotherapy
  • Adjuvant radiotherapy Adjuvant chemotherapy
  • Chemoradiation Concurrent Sequential
  • Durvalumab maintenance
  • Supportive and palliative care
  • Enrolment in a clinical trial